|
Re: ask Don?
|
8
|
Resverlogix Corp.
|
Oct 29, 2019 12:00PM
|
|
Re: archived presentation is up. still no audio
|
3
|
Resverlogix Corp.
|
Nov 18, 2019 02:12PM
|
|
Re: Apabetalone recudes ALP (apologies if repeat. looked on the new side)
|
3
|
Resverlogix Corp.
|
Jun 12, 2020 12:23AM
|
|
Re: Apabetalone recudes ALP (apologies if repeat. looked on the new side)
|
9
|
Resverlogix Corp.
|
Jun 11, 2020 12:30AM
|
|
Re: Apabetalone and Alkaline Phosphatase
|
3
|
Resverlogix Corp.
|
Oct 12, 2019 11:36AM
|
|
Re: Another article
|
5
|
Resverlogix Corp.
|
Nov 20, 2019 01:35PM
|
|
Re: Angiotensin and Coronavirus
|
3
|
Resverlogix Corp.
|
Mar 23, 2020 10:20PM
|
|
Re: Alzheimer's news
|
6
|
Resverlogix Corp.
|
Nov 04, 2019 04:14PM
|
|
Re: ALP Levels Predict Adverse Cardiovascular Outcomes And Cognitive Impairment In High Risk Patients
|
8
|
Resverlogix Corp.
|
Aug 08, 2019 02:15PM
|
|
Re: AGMs
|
4
|
Resverlogix Corp.
|
Oct 31, 2019 03:03PM
|
|
Re: ACE2 and Covid....Link to the Lancet article:
|
3
|
Resverlogix Corp.
|
Sep 25, 2020 12:29PM
|
|
Re: ACE2 and Covid
|
2
|
Resverlogix Corp.
|
Sep 25, 2020 06:29PM
|
|
Re: ACC 2019 Abstracts
|
4
|
Resverlogix Corp.
|
Mar 19, 2019 02:36PM
|
|
Re: ACC 2019 Abstracts
|
4
|
Resverlogix Corp.
|
Mar 19, 2019 03:24PM
|
|
Re: ACC 2019 Abstracts
|
4
|
Resverlogix Corp.
|
Mar 19, 2019 07:31PM
|
|
Re: ACC 2019 Abstracts
|
3
|
Resverlogix Corp.
|
Mar 04, 2019 03:40PM
|
|
Re: ACC 2019 Abstracts
|
3
|
Resverlogix Corp.
|
Mar 04, 2019 11:04PM
|
|
Re: AAC Poster Question on MoCA
|
8
|
Resverlogix Corp.
|
Mar 21, 2019 07:43PM
|
|
Re: A New Frontier in CV Risk Reduction for Patients With Type 2 Diabetes
|
7
|
Resverlogix Corp.
|
Dec 17, 2018 11:48AM
|
|
Re: A hunch about the below median LDL-C observation
|
3
|
Resverlogix Corp.
|
Nov 20, 2019 03:31PM
|
